Browse

You are looking at 1,251 - 1,300 of 1,314 items for

  • Refine by Access: All content x
Clear All
Restricted access

Chapter 11: Gastrointestinal Disorders and Nutrition

Lisa C. Hutchison and Rebecca B. Sleeper

Restricted access

Chapter 12: Psychiatric Issues

Amie Taggart Blaszczyk and Lisa C. Hutchison

Restricted access

Chapter 13: Psychiatric Issues

Monica Mathys and Myra T. Belgeri

Restricted access

Chapter 14: Pain and Sensory Disorders

Meri Hix

Restricted access

Chapter 15: Musculoskeletal and Connective Tissue Disorders

Mary Beth O’Connell and Michelle A. Fritsch

Restricted access

Chapter 16: Anemia and Preventive Therapy

Sum Lam, James J. Nawarskas, and Angela Cheng-Lai

Restricted access

Chapter 17: Infections and Antimicrobial Stewardship

Rebecca B. Sleeper and Kelsey L. Van Gorkom

Restricted access

Chapter 2: Ethical and Socioeconomic Considerations

Susan W. Miller

Restricted access

Chapter 3: Biomedical Principles of Aging

Lisa C. Hutchison

Restricted access

Chapter 4: Geriatric Assessment

Sunny A. Linnebur

Restricted access

Chapter 5: Adverse Drug Events, Polypharmacy, and Medication Management

Emily R. Hajjar, Joseph T. Hanlon, and Robert L. Maher Jr.

Restricted access

Chapter 6: Palliative and Hospice Care

Lisa C. Hutchison and Lindsey Dayer

Restricted access

Chapter 7: Cardiovascular Disorders

Kristen M. Cook

Restricted access

Chapter 8: Respiratory Disorders

Michael R. Brodeur

Restricted access

Chapter 9: Renal and Urologic Disorders

Erica L. Estus, Nicole J. Asal, and Norma J. Owens

Restricted access
Cover Fundamentals of Geriatric Pharmacotherapy

Fundamentals of Geriatric Pharmacotherapy

Edited by Lisa C. Hutchison and Rebecca B. Sleeper

Restricted access

American College of Cardiology/American Heart Association Guidelines

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Are Statins Safe to Use in Patients with Chronic Liver Disease?

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Bile Acid Sequestrants

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Can Fibrates Be Safely Added to a Statin for the Management of Hypertriglyceridemia?

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Cholesterol Absorption Inhibitors

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Clinical Presentation, Diagnosis, and Disease Classification

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Conclusion

Edited by Douglas A. Miller and James E. Tisdale

Restricted access

Do Statins Cause or Worsen Type 2 Diabetes?

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access
Cover Dyslipidemia: Contemporary Evaluation and Management eReport

Dyslipidemia: Contemporary Evaluation and Management eReport

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access
Cover Evaluating Patients for Drug-Induced Disease eReport

Evaluating Patients for Drug-Induced Disease eReport

Edited by Douglas A. Miller and James E. Tisdale

Restricted access

Fibric Acid Derivatives

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Figure 1-1: Approach to Management of Dyslipidemia

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Introduction

Edited by Douglas A. Miller and James E. Tisdale

Restricted access

MedWatch Program and Reporting Systems

Edited by Douglas A. Miller and James E. Tisdale

Restricted access

National Lipid Association Recommendations

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Nicotinic Acid

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Omega-3 Fatty Acids

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

References

Edited by Douglas A. Miller and James E. Tisdale

Restricted access

Should All Patients with an Acute Coronary Event or at High CHD Risk Be Started on High-Dose Statin Therapy?

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Should Co-enzyme Q10 Be Recommended for the Treatment and/or Prevention of Statin-Associated Muscle Aches?

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Statins

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Suggested Reading

Edited by Douglas A. Miller and James E. Tisdale

Restricted access

Suggested Reading

Edited by Douglas A. Miller and James E. Tisdale

Restricted access

Table 1-1: Cholesterol Concentrations

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Table 1-10. Drugs that Can Lead to or Worsen Dyslipidemias

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Table 1-11. Relative LDL-Lowering Efficacy of Statin and Statin-Based Therapies

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Table 1-12: Lipid Effects of Nonstatin Agents

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Table 1-13: Clinical Conditions that Can Worsen Lipid Profiles

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Table 1-2: Epidemiologic Data for Dyslipidemia

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Table 1-3: Comparison of ATP-III Guidelines, ACC/AHA 2013 Guidelines, and NLA Recommendations

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Table 1-4: Major Risk Factors for ASCVD

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Table 1-5: Criteria for Classification of ASCVD

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Table 1-6: National Lipid Association Criteria for ASCVD Risk Assessment, Treatment Goals for Atherogenic Cholesterol, and Levels to Consider Drug Therapy

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Restricted access

Table 1-7: Components of Dietary Recommendations

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch